证券记录 · 已归档季度
VCYT
Veracyte, Inc. · Healthcare · Medical - Diagnostics & Research
14被追踪持有人
+1Δ持有人
14.22M持有股份
$484.20M报告持仓市值
+3新建仓位
−2清仓
动量输入（同类管理人）：
持有人广度 +7.7% ·
股份流向 -21.1% ·
净新建仓位 +7.1%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2024
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 119 | +4 | 67.58M | $3.96B | +10 | −6 |
| Q1 2026 | 118 | +6 | 67.37M | $2.17B | +10 | −4 |
| Q4 2025 | 112 | 0 | 69.04M | $2.91B | +2 | −2 |
| Q3 2025 | 18 | -2 | 46.98M | $1.61B | — | −3 |
| Q2 2025 | 18 | 0 | 39.06M | $1.06B | +1 | −1 |
| Q1 2025 | 15 | -1 | 15.53M | $460.45M | — | −1 |
| Q4 2024 | 16 | +1 | 17.75M | $702.81M | +1 | — |
| Q3 2024 | 14 | +1 | 14.22M | $484.20M | +3 | −2 |
| Q2 2024 | 13 | — | 18.04M | $390.85M | — | — |
持有人 · Q3 2024
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | ARK Investment Management ✦ | 4.92M | -27.7% | $167.50M | 1.5% | ▼ Trim | 2 | SEC ↗ |
| 2 | Wellington Management ✦ | 4.23M | -38.4% | $144.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | Wellington Management ✦ | 4.23M | -38.4% | $144.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | Wellington Management ✦ | 4.23M | -38.4% | $144.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Wellington Management ✦ | 4.23M | -38.4% | $144.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | Wellington Management ✦ | 4.23M | -38.4% | $144.09M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | Geode Capital Management ✦ (被动) | 1.84M | +1.0% | $62.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 8 | Geode Capital Management ✦ (被动) | 1.84M | +1.0% | $62.81M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 9 | Fisher Asset Management ✦ | 877.76K | -1.4% | $29.88M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | Renaissance Technologies ✦ | 594.30K | +41.2% | $20.23M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 11 | Citadel Advisors ✦ | 500.37K | +950.3% | $17.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 12 | Citadel Advisors ✦ | 500.37K | +950.3% | $17.03M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 13 | Millennium Management ✦ | 335.51K | +422.4% | $11.42M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 14 | Arrowstreet Capital ✦ | 271.25K | 新增 | $9.23M | 0.0% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 190.29K | +225.8% | $6.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 190.29K | +225.8% | $6.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 190.29K | +225.8% | $6.48M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 18 | Norges Bank ✦ (被动) | 187.96K | +20.2% | $6.40M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 19 | Marshall Wace ✦ | 110.09K | 新增 | $3.75M | 0.0% | New | 1 | SEC ↗ |
| 20 | D. E. Shaw & Co. ✦ | 95.03K | 新增 | $3.23M | 0.0% | New | 1 | SEC ↗ |
| 21 | T. Rowe Price ✦ | 46.60K | +4.2% | $1.59M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 22 | Gotham Asset Management ✦ | 16.51K | +9.6% | $561,932 | 0.0% | ▲ Add | 2 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Arrowstreet Capital | $9.23M | 0.0% |
| Marshall Wace | $3.75M | 0.0% |
| D. E. Shaw & Co. | $3.23M | 0.0% |
已清仓
| Point72 Asset Management | $12.28M | 曾为 0.0% |
| Duquesne Family Office | $5.63M | 曾为 0.2% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 333 持有人, 87.61M 股份, $2.75B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2024 ·
方法论 ·
通过API获取此数据